AVROBIO, Inc. (14)
Browse by Contract Category
Contracts
-
Underwriting Agreement, dated November 19, 2020, between AVROBIO, Inc. Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named...
(Filed With SEC on November 20, 2020)
-
Separation Agreement and Release, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated July 16, 2020
(Filed With SEC on August 6, 2020)
-
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on March 16, 2020)
-
Amendment No. 1 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated February 21, 2018
(Filed With SEC on March 16, 2020)
-
First Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan
(Filed With SEC on June 9, 2020)
-
Amendment No. 2 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated January 7, 2020
(Filed With SEC on March 16, 2020)
-
Employment Agreement, by and between the Registrant and Deanna Petersen, dated September 1, 2018
(Filed With SEC on March 16, 2020)
-
Underwriting Agreement, dated February 12, 2020, between AVROBIO, Inc., and Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters...
(Filed With SEC on February 13, 2020)
-
Underwriting Agreement, dated July 16, 2019, between AVROBIO, Inc. Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named therein
(Filed With SEC on July 17, 2019)
-
Employment Agreement, by and between the Registrant and Steven Avruch, dated December 17, 2018
(Filed With SEC on March 25, 2019)
-
Consulting Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018
(Filed With SEC on March 25, 2019)
-
Employment Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018
(Filed With SEC on March 25, 2019)
-
Separation Agreement and Release, dated January 8, 2019, by and between the Company and Katina Dorton
(Filed With SEC on January 11, 2019)
-
Separation Agreement and Release, dated January 10, 2019, by and between the Company and Nerissa Kreher, M.D
(Filed With SEC on January 11, 2019)